Related Experiment Video
Updated: May 4, 2026

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
Published on: August 29, 2017
Broadly neutralizing antibodies and the promise of universal vaccines: where are we now?
1University of Toronto, Toronto, Ontario, Canada and Cornell University, Ithaca, NY, USA. klh22@cornell.edu.
Abstract:
Recent research has provided strong support for the utility of broadly neutralizing antibodies generated against viruses, which inherently possess a high degree of antigenic variability (such as influenza virus or HIV) as a feasible means to prevent infection. Many of these antibodies share the ability to bind to highly conserved regions within the stem of the virus 'spike' or surface glycoprotein, in such a way that they interfere with virus entry, including membrane fusion. As a result, broadly neutralizing antibodies could be supplied to patients as a form of passive immunotherapy, as well as play a role in the design of new 'universal' vaccines and antiviral agents. The following article describes the most recent innovations in this exciting field.
More Related Videos
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
04:47A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
Published on: February 23, 2018
Related Concept Videos
Vaccines
Vaccinations
Cross-reactivity
Humoral Immune Responses
Microorganisms in Medicine and Therapeutics
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...